Endologix

Endologix, Inc. is singularly focused on providing innovative, minimally invasive technologies for aortic disorders. The Company's product offering includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Designed around key issues with challenging anatomies, difficult access, and aneurysm sealing, Endologix products have been clinically proven in delivering positive patient outcomes. 

Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1992
Size (employees)
782 (est)
Endologix was founded in 1992 and is headquartered in Irvine, US

Endologix Office Locations

Endologix has offices in Irvine and Rosmalen
Irvine, US (HQ)
2 Musick
Rosmalen, NL
40 Burgemeester Burgerslaan

Endologix Financials and Metrics

Endologix Financials

Endologix's revenue was reported to be $192.9 m in FY, 2016
USD

Revenue (Q2, 2017)

48.6 m

Gross profit (Q2, 2017)

32.2 m

Gross profit margin (Q2, 2017), %

66%

Net income (Q2, 2017)

(16.3 m)

EBIT (Q2, 2017)

(7.9 m)

Market capitalization (13-Dec-2017)

443.4 m

Cash (30-Jun-2017)

81.6 m
Endologix's current market capitalization is $443.4 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

132.3 m147.6 m153.6 m192.9 m

Revenue growth, %

12%4%26%

Cost of goods sold

41.8 m51.8 m69.1 m

Gross profit

105.8 m101.8 m123.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

33.3 m33.3 m38.3 m37.2 m36.7 m39.5 m38.2 m42.4 m51 m52.1 m42.6 m48.6 m

Cost of goods sold

7.4 m9 m9.8 m13.6 m9.8 m15.3 m11.2 m14.4 m21.5 m15.2 m14 m16.3 m

Gross profit

25.9 m24.3 m28.5 m23.6 m26.9 m24.1 m27 m27.9 m29.5 m36.9 m28.6 m32.2 m

Gross profit Margin, %

78%73%74%63%73%61%71%66%58%71%67%66%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

95.2 m26.8 m124.6 m26.1 m

Accounts Receivable

310 k498 k375 k1.8 m

Inventories

19.6 m31.3 m27.9 m41.2 m

Current Assets

173.6 m147.8 m237.5 m129.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

49.5 m42.2 m31.8 m27.5 m20.2 m36.3 m35.4 m39.8 m31.4 m22 m15.5 m81.6 m

Accounts Receivable

312 k690 k910 k878 k448 k121 k304 k2.6 m825 k659 k952 k390 k

Inventories

18 m24 m28.5 m27.7 m35.1 m30.6 m33.4 m43.3 m42.1 m43.4 m42.7 m43.6 m

Current Assets

93.4 m172.3 m170.7 m158.4 m138.4 m133 m132.3 m172.3 m155.3 m148.5 m113 m175.8 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(32.4 m)(50.4 m)(154.7 m)

Depreciation and Amortization

3.3 m5.9 m9.1 m

Inventories

(12 m)3.5 m3.5 m

Accounts Payable

2.7 m8.3 m(5.2 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(9 m)5.3 m(9 m)(13.9 m)(11.2 m)(13 m)(10.9 m)(47.7 m)(66.8 m)(15.2 m)(21.3 m)

Accounts Receivable

910 k878 k448 k121 k304 k2.6 m825 k659 k952 k

Inventories

28.5 m27.7 m35.1 m30.6 m33.4 m43.3 m42.1 m43.4 m42.7 m

Accounts Payable

11.5 m10.8 m11.1 m11.8 m13.8 m15.7 m13.8 m13 m9.6 m
Y, 2017

Financial Leverage

4.2 x
Show all financial metrics

Endologix Market Value History

Endologix's Web-traffic and Trends

Endologix Online and Social Media Presence

Endologix Company Life and Culture

You may also be interested in